צמיחת מכירות משנה לשנה ב-12 החודשים האחרונים: Neurocrine Corp (NBIX)

Neurocrine Biosciences (NBIX) efficiency is based on robotic bioscreening, which accelerates the discovery of neuropreparations. The annual revenue growth trend over a rolling 12-month period clearly captures the sales vector, where the value of 37.90 describes the current level. Long-term treatment courses for chronic pathologies ensure revenue stability, while the patent-protected Ingrezza acts as a high-margin cash cow, maintaining the company's operational momentum.
Neurocrine (NBIX) - פילוחי מדדים ודוחות פיננסיים

This indicator measures the percentage change in aggregate revenue over the last twelve months relative to the same period last year, allowing for the filtering of short-term market noise. By analyzing the year-over-year sales growth rate over a rolling four-quarter period, the investor assesses the effectiveness of the organic development pipeline of Neurocrine Biosciences (NBIX) and the monetization of molecule rights acquired through strategic licensing agreements.